Search

Search Results
Results 19141 - 19150 of 19173 for stroke
  • Teveten Plus
    Drug - 16 Feb 2022
    Consumer Medicine Information (CMI) about Teveten Plus intended for persons living in Australia.
  • Fenofibrate Viatris
    Drug - 25 Jan 2022
    Consumer Medicine Information (CMI) about Fenofibrate Viatris intended for persons living in Australia.
  • Mabcampath
    Drug - 10 Jan 2022
    Consumer Medicine Information (CMI) about Mabcampath intended for persons living in Australia.
  • Lipidil
    Drug - 3 Dec 2021
    Consumer Medicine Information (CMI) about Lipidil intended for persons living in Australia.
  • Champix
    Drug - 22 Nov 2021
    Consumer Medicine Information (CMI) about Champix intended for persons living in Australia.
  • Oxytrol
    Drug - 16 Jun 2021
    Consumer Medicine Information (CMI) about Oxytrol intended for persons living in Australia.
  • Fluanxol
    Drug - 7 Oct 2020
    Consumer Medicine Information (CMI) about Fluanxol (Flupentixol decanoate) intended for persons living in Australia.
  • Duodopa
    Drug - 23 Apr 2020
    Consumer Medicine Information (CMI) about Duodopa intended for persons living in Australia.
  • The Quest for an Acute Traumatic Brain Injury Treatment
    Health - 26 Jun 2019
    Traumatic brain injury (TBI) is a leading cause of death and disability in the United States, contributing to as many as a third of injury-related deaths. When a patient presents to the emergency...
  • Test document
    Drug - 17 Jan 2019
    Consumer Medicine Information (CMI) about Test document (darbepoetin alfa) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback